Sciclone pharmaceuticals linkedin
Web16 Sep 2024 · For SciClone Pharmaceuticals [email protected] [email protected] For Tarveda Therapeutics Amanda Houlihan MacDougall: 781 235 3060 [email protected] Release Summary WebClifford Chance. Sep 2024 - Present4 years 7 months. Hong Kong. Working as a US associate with the capital markets team. · Advised the issuer on the HKEX listing and/or international placing of: SenseTime Group Inc. (2024) - weighted voting right structure. SciClone Pharmaceuticals (2024) Haier Smart Home (2024) - listing by way of introduction.
Sciclone pharmaceuticals linkedin
Did you know?
WebSciClone Pharmaceuticals Aug 2024- Present1 year 9 months CStone Pharmaceuticals 2 years 3 months Associate Manager, Portfolio Strategy … WebCB Rank (Person) 69,178. Location San Francisco Bay Area, California, United States. Regions West Coast, Western US. Gender Male. LinkedIn View on LinkedIn. Dr. Friedhelm Blobel, Ph.D. is President, Chief Executive Officer, Director of SciClone Pharmaceuticals, Inc. He was appointed as Acting Chief Financial Officer of the Company on May 31, 2013.
WebShangri-La Group. Jun 2024 - Present3 years 11 months. Hong Kong SAR. At dawn, the sun rises over Kowloon Shangri-La, just as you wake up from your silk bedding and sweet dreams. Lobby Lounge ... WebDirector QA at SciClone Pharmaceuticals Richmond Hill, Ontario, Canada 735 followers 500+ connections Join to connect SciClone Pharmaceuticals Università degli Studi di Milano About At...
WebSciClone Pharmaceuticals Holding Limited Accountant Kowloon, Hong Kong SAR 8 connections. Join to connect SciClone Pharmaceuticals Holding Limited. Sacred Heart Canossian College of Commerce. Report this profile About PROFESSIONAL QUALIFICATION 1. Hong Kong Institute of Accredited Accounting Technicians (HKAAT) - Passed with 8 … WebSciClone Pharmaceuticals (Holdings) Limited operates as a biopharmaceutical company. The Company develops, produces and sells oncology drug, infectious diseases drugs, and other products. SciClone ...
Web8 Jun 2024 · SciClone Pharmaceuticals, Inc. is a revenue-generating, specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
Web8 Jun 2024 · SciClone Pharmaceuticals, Inc. is a revenue-generating, specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic... hardbase flashingWebIP and Legal Affairs Administrator at SciClone Pharmaceuticals San Mateo, California, United States. 3 followers 1 connection. Join to connect SciClone Pharmaceuticals ... hard bartholin cystWebSciclone Pharmaceuticals, Inc. Website. Get a D&B Hoovers Free Trial. Overview. Doing Business As: SciClone. Company Description: SciClone hopes its drug sales create a whirlwind in China. The drug firm's flagship product Zadaxin is approved for use in more than 30 countries, including China, its primary market. Zadaxin treats hepatitis B, as a ... hardbase construction chichesterWebMar 2015 - 20248 years. 4140 No. 3 Rd # 250, Richmond, BC. 5U® Website, a worry-free website production company, has been dedicated to providing high-quality web design and website production services for businesses, organizations and societies in the Greater Vancouver area for ten years. Our local web designers can communicate efficiently ... chanel cosmetics counterWeb31 Mar 2016 · So what: SciClone's management reported on March 10 that its revenue climbed 17% year over year to $157.3 million in 2015. Revenue came predominately from sales of Zadaxin, a hepatitis B treatment ... hard baseball capWeb27 Jan 2014 · FOSTER CITY, CA--(Marketwired - January 24, 2014) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Audit Committee of the Company's Board of Directors has appointed PricewaterhouseCoopers Zhong Tian LLP ("PwC China") to replace PricewaterhouseCoopers LLP ("PwC US") as the Company's … hard baseball glove caseWeb14 Jan 2013 · FOSTER CITY, CA--(Marketwire - January 14, 2013) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the appointment of Simon Li to its board of directors.Mr. Li is an accomplished and respected leader in the pharmaceutical and medical device industries in China and Asia, and brings to SciClone's board more than 30 … hard barricade